FDA Warning Wire: Pumps, Clinical Trials, Supplements
The FDA this week chided a New York-based device maker for selling infusion pumps without premarket approval for so-called class III medical devices considered to pose the highest risk. The agency...To view the full article, register now.
Already a subscriber? Click here to view full article